166 related articles for article (PubMed ID: 8656271)
21. Node positive melanoma--a positive note?
Kelly J; Kerin MJ
Surgeon; 2012 Apr; 10(2):63-4. PubMed ID: 22385525
[No Abstract] [Full Text] [Related]
22. Adjuvant therapy of melanoma: at what cost?
Spitler LE
J Clin Oncol; 2001 Feb; 19(4):1226-8. PubMed ID: 11181688
[No Abstract] [Full Text] [Related]
23. Low-dose adjuvant interferon for stage III malignant melanoma.
Inman JL; Russell GB; Savage P; Levine EA
Am Surg; 2003 Feb; 69(2):127-30. PubMed ID: 12641352
[TBL] [Abstract][Full Text] [Related]
24. Finally, a successful adjuvant therapy for high-risk melanoma.
Balch CM; Buzaid AC
J Clin Oncol; 1996 Jan; 14(1):1-3. PubMed ID: 8558183
[No Abstract] [Full Text] [Related]
25. Melanoma adjuvant therapy.
Tarhini AA; Thalanayar PM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):471-89. PubMed ID: 24880942
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy for high-risk primary and resected metastatic melanoma.
Hersey P
Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876
[TBL] [Abstract][Full Text] [Related]
27. How does interferon work? Does it even matter?
Sondak VK
Cancer; 2002 Sep; 95(5):947-9. PubMed ID: 12209676
[No Abstract] [Full Text] [Related]
28. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
29. The role of adjuvant interferon in high risk melanoma patients.
Dermatol Surg; 2000 Jun; 26(6):607-8. PubMed ID: 10848951
[No Abstract] [Full Text] [Related]
30. Therapy of melanoma with allogeneic melanoma lysates alone or with interferon-alfa.
Mitchell MS; Darrah D; Stevenson L
Cancer Invest; 2002; 20(5-6):759-68. PubMed ID: 12197233
[No Abstract] [Full Text] [Related]
31. [Adjuvant therapy of malignant melanoma].
Franke W; Neumann NJ; Ruzicka T; Schulte KW
Praxis (Bern 1994); 2001 Feb; 90(8):301-6. PubMed ID: 11256332
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant interferon for stage II melanoma.
Haluska FG
J Clin Oncol; 1998 Sep; 16(9):3205-6. PubMed ID: 9738597
[No Abstract] [Full Text] [Related]
33. [Therapeutic manual of malignant melanoma].
Moroi Y
Fukuoka Igaku Zasshi; 2009 Feb; 100(2):51-8. PubMed ID: 19455975
[No Abstract] [Full Text] [Related]
34. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
35. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
36. Current therapy of cutaneous melanoma.
Mays SR; Nelson BR
Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
[TBL] [Abstract][Full Text] [Related]
37. Approaches to regional nodes in patients with melanoma.
Deperalta DK; Hoang MP; Tanabe KK
J Clin Oncol; 2014 Mar; 32(9):881-5. PubMed ID: 24516017
[No Abstract] [Full Text] [Related]
38. The adjuvant treatment of malignant melanoma.
Reintgen D; Kirkwood J
J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
[TBL] [Abstract][Full Text] [Related]
39. What does ulceration of a melanoma mean for prognosis?
Callender GG; McMasters KM
Adv Surg; 2011; 45():225-36. PubMed ID: 21954690
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of cutaneous melanoma].
Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
